Testing version — LOERadar is in active testing. Features and data may change.
HYTRIN (TERAZOSIN HYDROCHLORIDE) | LOERadar
HYTRIN
NDA
TERAZOSIN HYDROCHLORIDE | N019057 | ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
4 strengths0 unique patents0 unique exclusivities
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
Para IV certification filed but no ANDA patent litigation cases (NOS 835) matched from PACER. Litigation may be pending or filed under a different caption.
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (4)
Sort:
#001 — EQ 1MG BASE
0 patents0 exclusivities▴
TABLET;ORAL | Approved: Aug 7, 1987
No patent or exclusivity listings for this strength.